Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
98.56USD
Average target price
108.50USD
Spread / Average Target
+10.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. INCY Stock
  4. ETFs Incyte Corporation